RecruitingOBSERVATIONAL

Assessing Biomarker in Giant Cell Arteritis and Polymyalgia Rheumatic

The GCAIO study is a new research project looking into Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR). The main goal is to improve our understanding, detection, and treatment of these conditions. Researchers are studying different body signals and immune cells to predict how GCA might progress and how it responds to treatments. They're also using modern scanning techniques like MRI and ultrasound to find problems earlier and monitor them better, especially in the eyes, heart, and major blood vessels. This research also hopes to improve diagnoses and treatment plans for PMR, ultimately aiming for better health outcomes for patients.

At a glance

Status

Recruiting

Sponsor

University of Bonn

Enrolment target

100

Start

01 Sep 2023

Estimated completion

30 Sep 2027

Giant Cell Arteritis Polymyalgia Rheumatica

What is this study about?

This important study, called GCAIO, is all about improving how we understand, diagnose, and look after people with Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR). These are conditions that involve inflammation in the body, and GCA can affect blood vessels throughout the body, sometimes leading to serious problems.

The researchers are focusing on a few key areas. Firstly, they want to understand the body's immune system better in people with GCA and PMR. By looking at specific cells and proteins in the blood, they hope to find ways to predict how the disease might behave and how well different treatments will work. They are also trying to create new tests that can show which treatments might be best for each person.

Secondly, the study is using advanced scanning techniques, like MRI and ultrasound, to get clearer pictures of the blood vessels and other parts of the body that might be affected. This could help doctors spot problems earlier, especially in the eyes, heart, and the main artery from the heart, which is really important for getting the right treatment quickly. Ultimately, the goal is to use all this information to create more precise ways to diagnose GCA and PMR and to offer new and improved treatment plans.

Key takeaways

This study is about understanding GCA and PMR better.
It uses advanced scans and blood tests to learn more.
The goal is to improve diagnosis and treatment for both conditions.
Researchers hope to find personalised treatments.
Your participation could help many people in the future.
You can stop participating at any time.

Who may be eligible?

Anyone aged 18 or over might be able to join this study if they have been diagnosed with Giant Cell Arteritis (GCA) or Polymyalgia Rheumatica (PMR) by their doctor. This diagnosis must have been made recently (in the last three days) or you must be experiencing a flare-up of your condition.

However, there are certain reasons why someone might not be able to take part. For example, if you have severe kidney problems, you wouldn't be able to join. Also, if you need to take steroid medication for another health condition besides GCA or PMR, you wouldn't be eligible.

Finally, if you have other inflammatory conditions that affect the joints or other parts of the body, different from GCA or PMR, you would also not be able to participate. The study is looking for people with specific circumstances related to their GCA or PMR diagnosis.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you 18 years old or older?
Have you been diagnosed with GCA or PMR by a doctor?
Was your diagnosis recent (within the last 3 days) or are you having a flare-up?
Do you have severe kidney problems (GFR less than 30 mL/min)? (If yes, you may not be eligible)
Do you take steroid medicines for another condition besides GCA or PMR? (If yes, you may not be eligible)
Do you have other inflammatory conditions like GCA or PMR? (If yes, you may not be eligible)

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, you would undergo various assessments. These might include imaging scans like MRI, ultrasound scans of blood vessels (including in your eyes and head), and specialised eye tests. You would also have blood tests so researchers can look at your immune cells and other markers. Some of these tests might be new or not routinely used yet. You would also fill out questionnaires about how you are feeling and how your condition is affecting you. The study aims to follow participants over time to see how the disease progresses and responds to treatment. The exact number of visits and the full duration of your participation would be discussed with you by the research team.

Potential risks and benefits

Taking part in this study could offer several potential benefits, such as contributing to a better understanding of GCA and PMR, which may lead to improved diagnoses and treatments for future patients. You might also receive closer monitoring of your condition. However, there are potential risks, like discomfort or minor risks associated with blood tests or imaging scans, which the research team will explain fully. You have the right to withdraw from the study at any time without having to give a reason, and this decision will not affect your usual medical care.

Locations (1)

University Hospital Bonn
Verified postcode
Bonn, Germany· Recruiting

Common questions

What are Giant Cell Arteritis (GCA) and Polymyalgia Rheumatica (PMR)?

They are conditions where the body's immune system causes inflammation, affecting blood vessels (GCA) or muscles and joints (PMR).

Why is this study important?

It aims to find better ways to diagnose GCA and PMR, understand how they work, and develop more effective and personalised treatments.

Will I receive new treatment in this study?

The study focuses on understanding and diagnosing, but the findings could lead to new treatments in the future. The researchers are also exploring personalised treatment approaches.

What kind of tests will I have?

You might have blood tests, MRI scans, ultrasound scans, and special eye tests to help researchers learn more about your condition.

Does taking part affect my regular medical care?

No, your decision to take part or withdraw will not affect the standard medical care you receive from your doctors.

How to find out more

Simon M. Petzinna, Dr. med.

simon_michael.petzinna@ukbonn.de 0049 151 582 337 07 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.